Allergan Confirms Generic Abraxane(R) Patent Challenge
DUBLIN, March 17, 2016 -- (Healthcare Sales & Marketing Network) -- Allergan plc (AGN), a leading global pharmaceutical company, today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) ... Biopharmaceuticals, Generics, FDAAllergan, Abraxane, Paclitaxel
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Abraxane | Allergy | Food and Drug Administration (FDA) | Marketing | New Drug Applications | Pharmaceuticals